Changing the Lives of People With Primary Immunodeficiencies (PI) With Early Testing and Diagnosis

Imagem de Miniatura
Arquivos
art_CONDINO-NETO_Changing_the_Lives_of_People_With_Primary_Immunodeficiencies_2018.PDF (138.03 KB)
Citações na Scopus
23
Tipo de produção
article
Data de publicação
2018
Editora
FRONTIERS MEDIA SA
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
ESPINOSA-ROSALES, Francisco J.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
FRONTIERS IN IMMUNOLOGY, v.9, article ID 1439, 4p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Throughout the world, primary immunodeficiencies (PI) are largely undiagnosed and underreported. Many patients do not receive an accurate and timely diagnosis, which is crucial for successful management and care of PI (1). It is estimated that between 70 and 90% of people living with a PI still remain undiagnosed worldwide (2). As for many other rare diseases, early testing and diagnosis are essential first steps in the care pathway toward timely and appropriate care and treatment, which are ultimately life changing and life enhancing for people living with PI. Under the theme ""My future starts with early testing and diagnosis of PI,"" the eighth annual World Primary Immunodeficiency Week (World PI Week), celebrated from the 22nd to the 29th of April 2018, raised awareness of early recognition of PI, pursuing the goal of the campaign of ensuring an improved quality of life for people living with these diseases worldwide.
Palavras-chave
primary immunodeficiencies, diagnosis, treatment, morbidity, mortality
URI
https://observatorio.fm.usp.br/handle/OPI/28505
Referências
  1. [Anonymous], 2014, RED FLAGS PRIM IMM I
  2. Bousfiha AA, 2013, J CLIN IMMUNOL, V33, P1, DOI 10.1007/s10875-012-9751-7
  3. Bousfiha A, 2018, J CLIN IMMUNOL, V38, P129, DOI 10.1007/s10875-017-0465-8
  4. Chapel H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00627
  5. Costa-Carvalho B, 2017, EXPERT REV CLIN IMMU, V13, P483, DOI 10.1080/1744666X.2017.1255143
  6. Costa-Carvalho BT, 2014, J CLIN IMMUNOL, V34, P10, DOI 10.1007/s10875-013-9954-6
  7. Cunningham-Rundles C, 2004, J ALLERGY CLIN IMMUN, V113, P747, DOI 10.1016/j.jaci.2004.01.761
  8. de Vries E, 2012, CLIN EXP IMMUNOL, V167, P108, DOI 10.1111/j.1365-2249.2011.04461.x
  9. Gardulf A, 2004, J ALLERGY CLIN IMMUN, V114, P936, DOI 10.1016/j.jaci.2004.06.053
  10. GARDULF A, 1995, LANCET, V345, P365
  11. Immune Deficiency Foundation, 2009, PRIM IMM DEF DIS AM
  12. Immune Deficiency Foundation, 2015, DIAGN CLIN CAR GUID
  13. IPOPI, 2017, TACKL DIAGN OD RAR D
  14. IPOPI, 2012, PRIM IMM DIAGN PRIM
  15. King J, 2017, INT J NEONATAL SCREE, V3, P19, DOI 10.3390/IJNS3030019
  16. Modell F, 2009, IMMUNOL RES, V44, P132, DOI 10.1007/s12026-008-8092-3
  17. Modell V, 2018, IMMUNOL RES, V66, P367, DOI 10.1007/s12026-018-8996-5
  18. Rezaei N, 2017, PRIMARY IMMUNODEFICI
  19. Selenius JS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01190
  20. Therrell BL, 2015, SEMIN PERINATOL, V39, P171, DOI 10.1053/j.semperi.2015.03.002

Coleções
Artigos e Materiais de Revistas Científicas - LIM/46